Back to MORGAN STANLEY MORGAN STANLEY

PYXSPYXS
8 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in PYXIS ONCOLOGY INC

MORGAN STANLEY holds 69,688 shares of PYXS (PYXIS ONCOLOGY INC), worth $101,744 as of 2026-Q1. The position was decreased (-21.9% shares).

Current Value

$101,744

Current Shares

69,688

Total Value Change

-$171,699

Total Shares Change

-12,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Decreased
69,688
-21.9%
$101,7440.0%$1.43
0
2025-Q4
Decreased
89,222
-16.3%
$102,6060.0%$1.09
0
2025-Q3
Decreased
106,607
-33.4%
$236,6670.0%$2.20
0
2025-Q2
Decreased
160,174
-64.1%
$176,1920.0%$1.10
0
2025-Q1
Increased
446,482
+83.9%
$437,5080.0%$1.06
25
2024-Q4
Increased
242,731
+58.4%
$378,6600.0%$1.56
23
2024-Q3
Increased
153,248
+85.5%
$562,4200.0%$3.62
26
2024-Q2
New
82,611
-
$273,4430.0%$3.31
36

Other major holders of PYXS: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, CITADEL ADVISORS LLC, Janus Henderson Group Ltd., BALYASNY ASSET MANAGEMENT L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used